Ah Chan, a recent Executive MBA (Chinese) programme graduate of The Chinese University of Hong Kong (CUHK) Business School, was the first business student to successfully execute an initial public offering (IPO) for a company during his time at CUHK. Wuhan Hiteck Biological Pharma Company Limited(武漢海特生物製藥股份有限公司), founded by Chan, had a registered capital of RMB 60 million yuan when it went public on the Shenzhen Stock Exchange in 2017. It is currently valued at RMB 3 billion yuan.